4//SEC Filing
Shacham Sharon 4
Accession 0001209191-21-022487
CIK 0001503802other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 7:50 AM ET
Size
5.9 KB
Accession
0001209191-21-022487
Insider Transaction Report
Form 4
Shacham Sharon
CSO & Pres. Res. & Dev.
Transactions
- Sale
Common Stock
2021-03-18$12.39/sh−4,000$49,553→ 714,826 total(indirect: By Spouse)
Holdings
- 920,152
Common Stock
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.
- [F2]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.29 to $12.56, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001588438
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 7:50 AM ET
- Size
- 5.9 KB